
3 September 2025
Breakthrough in mitochondria therapy: CSEM and cellvie automate isolation process for clinical use
cellvie and CSEM are advancing an automated solution to standardize mitochondrial therapy manufacturing, accelerating treatment for ischemia-reperfusion injury and potentially helping over 3 million patients annually in Europe and the USA.